Literature DB >> 22225918

Micro-dissecting the pathogenesis and immune response of PRRSV infection paves the way for more efficient PRRSV vaccines.

H J Nauwynck1, H Van Gorp, M Vanhee, U Karniychuk, M Geldhof, A Cao, M Verbeeck, W Van Breedam.   

Abstract

Porcine reproductive and respiratory syndrome virus (PRRSV) is the most important infectious pathogen in pigs worldwide nowadays. Due to its genetic drift and increasing power to escape from immunity, PRRSV becomes more and more difficult to control. Based on a better knowledge of PRRSV, its interaction with the host cell, the macrophage, its pathogenesis and the immunity against this virus, new vaccines can now be constructed. This research-based development of new generation vaccines will allow swine industry to face the devastating consequences of PRRSV infections in the future. The present review summarizes the present knowledge on the pathogenesis, the immune response and the research-based vaccine development.
© 2012 Blackwell Verlag GmbH.

Entities:  

Keywords:  PRRSV; immune response; pathogenesis; vaccine

Mesh:

Substances:

Year:  2012        PMID: 22225918     DOI: 10.1111/j.1865-1682.2011.01292.x

Source DB:  PubMed          Journal:  Transbound Emerg Dis        ISSN: 1865-1674            Impact factor:   5.005


  8 in total

1.  The polymorphism analysis of CD169 and CD163 related with the risk of porcine reproductive and respiratory syndrome virus (PRRSV) infection.

Authors:  Y W Ren; Y Y Zhang; N A Affara; C A Sargent; L G Yang; J L Zhao; L R Fang; J J Wu; R Fang; Q Tong; J Xiao; J L Li; Y B Jiang; H C Chen; S J Zhang
Journal:  Mol Biol Rep       Date:  2012-06-28       Impact factor: 2.316

2.  Integrative model of the immune response to a pulmonary macrophage infection: what determines the infection duration?

Authors:  Natacha Go; Caroline Bidot; Catherine Belloc; Suzanne Touzeau
Journal:  PLoS One       Date:  2014-09-18       Impact factor: 3.240

3.  Modified-live PRRSV subtype 1 vaccine UNISTRAIN® PRRS provides a partial clinical and virological protection upon challenge with East European subtype 3 PRRSV strain Lena.

Authors:  Caroline Bonckaert; Karen van der Meulen; Isaac Rodríguez-Ballarà; Rafael Pedrazuela Sanz; Mar Fenech Martinez; Hans J Nauwynck
Journal:  Porcine Health Manag       Date:  2016-05-09

4.  How to prevent viremia rebound? Evidence from a PRRSv data-supported model of immune response.

Authors:  Natacha Go; Suzanne Touzeau; Zeenath Islam; Catherine Belloc; Andrea Doeschl-Wilson
Journal:  BMC Syst Biol       Date:  2019-01-29

Review 5.  Pathogenesis and prevention of placental and transplacental porcine reproductive and respiratory syndrome virus infection.

Authors:  Uladzimir U Karniychuk; Hans J Nauwynck
Journal:  Vet Res       Date:  2013-10-07       Impact factor: 3.683

6.  Changes in leukocyte subsets of pregnant gilts experimentally infected with porcine reproductive and respiratory syndrome virus and relationships with viral load and fetal outcome.

Authors:  Andrea Ladinig; Wilhelm Gerner; Armin Saalmüller; Joan K Lunney; Carolyn Ashley; John C S Harding
Journal:  Vet Res       Date:  2014-12-14       Impact factor: 3.683

Review 7.  Immune Control of PRRS: Lessons to be Learned and Possible Ways Forward.

Authors:  Massimo Amadori; Elisabetta Razzuoli
Journal:  Front Vet Sci       Date:  2014-10-14

8.  Transcriptional Immune Signatures of Alveolar Macrophages and the Impact of the NLRP3 Inflammasome on Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Replication.

Authors:  Julie A Hicks; Dongwan Yoo; Hsiao-Ching Liu
Journal:  Viruses       Date:  2020-11-12       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.